RTW Biotech portfolio firm Aktis raises USD318 million in US IPO
(Alliance News) - RTW Biotech Opportunities Ltd on Monday said its portfolio company Aktis Oncology Inc has completed a USD318 million IPO on New York's Nasdaq, the first biotech listing of 2026. Read More